A beta-lactam-resistant Bacteroides uniformis strain was isolated from a clinical specimen. The strain produced large amounts of -lactamase and was resistant to penicillins and cephalosporins. The specific activity of the unpurified -lactamase was 4.8 U/mg of protein with nitrocefin as the substrate. The enzyme was purified 188-fold by Q-Sepharose, Sephacryl S-300, and Mono Q column passages. Kinetic parameters of the enzyme were determined by a micromethod performed in microtiter plates. -Lactamase was inhibited by cefoxitin and imipenem and hydrolyzed cephalosporins more rapidly than penicillins. The molecular weight was determined by sodium dodecyl sulfate-gradient gel electrophoresis to be 32,500, and the isoelectric point was 4.5.Resistance to antimicrobial agents in Bacteroides spp. is mediated by several mechanisms. The most important mechanism of resistance to beta-lactam antibiotics to date is -lactamase production. -Lactamases are produced by a majority of resistant isolates of the Bacteroides fragilis group as well as by other anaerobes (17). At least four types of -lactamases have been described for members of the B. fragilis group, but the most common type is a constitutively produced, chromosomally encoded cephalosporinase that has no activity against cefoxitin and imipenem. Recent studies have shown that at least 90% of all B. fragilis group strains produce -lactamases and that 25% of the strains produce high levels of -lactamase (7). Members of the B. fragilis group of organisms are the anaerobic bacterial pathogens most frequently recovered from humans. Bacteroides uniformis is not often found in anaerobic infections. It accounts for less than 5% of the B. fragilis group species found in clinical specimens (11). The aim of this study was to purify and characterize a -lactamase produced by B. uniformis by a microtechnique for determination of kinetic parameters and enzyme inhibition.
MATERIALS AND METHODSBacterial strain. B. uniformis B 371 was isolated from a wound in a kidney transplant patient at the Huddinge University Hospital, Stockholm, Sweden. The strain was identified by the procedures of Holdeman et al. (14).Antimicrobial agents. The following agents were tested: ampicillin and benzylpenicillin (Astra, Södertälje, Sweden), cefoxitin and imipenem (Merck Sharp & Dohme, West Point, Pa.), cephalothin (Eli Lilly and Co., Indianapolis, Ind.), piperacillin (Lederle, Pearl River, N.Y.), and cephaloridine and nitrocefin (Glaxo Pharmaceuticals, Greenford, United Kingdom).Antimicrobial susceptibility tests. MICs were determined by the agar dilution method on paper disc method agar (AB Biodisk, Solna, Sweden) with the addition of 5% defibrinated horse blood. The inoculum was approximately 10 6 CFU/ml and was applied by a Steers replicator and incubated for 48 h at 37ЊC in anaerobic jars (GasPak; BBL Microbiology Systems, Cockeysville, Md.).Medium. The medium used was prereduced proteose peptone-yeast extract medium prepared as described previously (20).Production of -lactamase. B. uniform...